Different dose groups:Injection dose

2 trials

Sponsors

Nanjing University

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Phase 1

A single center clinical study of evaluating the injection of microRNA2911 plasmid in healthy adults

Active, not recruitingITMCTR2000003169

Nanjing UniversityNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-05-01Updated: 2023-02-20

A single center clinical study of evaluating the injection of microRNA2911 plasmid in healthy adults

Active, not recruitingChiCTR2000031432

Nanjing UniversityNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-05-01Updated: 2020-04-06